| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 5,204,211 | 5,388,019 |
| Net increase in cash and cash equivalents | 680,239 | 2,291,586 |
| Cash and cash equivalents at beginning of period | 3,696,870 | - |
| Cash and cash equivalents at end of period | 4,377,109 | - |
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)